title: Unresectable fibrolamellar hepatocellular carcinoma treated with intra-arterial lipiodolised doxorubicin. A case report.
abstract: Hepatocellular carcinoma is often an aggressive tumour and, if unresectable, carries a poor prognosis, especially in the presence of jaundice. We report on a jaundiced patient with an unresectable fibrolamellar hepatocellular carcinoma treated with intra-arterial lipiodolised doxorubicin (Adriamycin). The initial response of the patient has been encouraging. This form of therapy deserves further evaluation in patients with unresectable hepatocellular carcinoma.
authors.affiliation: Department of Surgery, University of Cape Town.
authors.forename: R A
authors.initials: RA
authors.lastname: Spence
authors.forename: A
authors.initials: A
authors.lastname: Rosen
authors.forename: J E
authors.initials: JE
authors.lastname: Krige
authors.forename: R L
authors.initials: RL
authors.lastname: Blumgart
authors.forename: C R
authors.initials: CR
authors.lastname: Temple-Camp
authors.forename: J
authors.initials: J
authors.lastname: Terblanche
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007261:Infusions, Intra-Arterial; D007459:Iodized Oil / Q000008:administration & dosage*; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male
chemical_list: D007459:Iodized Oil; D004317:Doxorubicin